These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11718142)

  • 1. Nonmyeloablative allogeneic stem-cell transplantation for malignancy.
    Tecnologica MAP Suppl; 2001 Apr; ():14-7. PubMed ID: 11718142
    [No Abstract]   [Full Text] [Related]  

  • 2. Salvage high-dose chemotherapy with allogeneic stem-cell support for relapse or incomplete remission following high-dose chemotherapy with autologous stem-cell transplantation for hematologic malignancies.
    Tecnologica MAP Suppl; 2000 Jun; ():16-9. PubMed ID: 11067684
    [No Abstract]   [Full Text] [Related]  

  • 3. Salvage high-dose chemotherapy with allogeneic stem-cell support for relapse following high dose chemotherapy with autologous stem-cell support for solid tumors.
    Tecnologica MAP Suppl; 1999 Jun; ():16-7. PubMed ID: 10848040
    [No Abstract]   [Full Text] [Related]  

  • 4. High dose lymphoablative therapy (HDLT) with or without stem cell rescue for treatment of severe autoimmune diseases.
    Tecnologica MAP Suppl; 2000 Apr; ():10-2. PubMed ID: 11010674
    [No Abstract]   [Full Text] [Related]  

  • 5. High-dose chemotherapy with autologous stem-cell support for epithelial ovarian cancer.
    Tecnologica MAP Suppl; 1998 Feb; ():15-7. PubMed ID: 10183353
    [No Abstract]   [Full Text] [Related]  

  • 6. FDG PET for evaluating breast cancer.
    Tecnologica MAP Suppl; 2001 Apr; ():7-13. PubMed ID: 11718146
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose chemotherapy with autologous stem-cell support for epithelial ovarian cancer.
    Tecnologica MAP Suppl; 1999 Jan; ():5-7. PubMed ID: 10346739
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose chemotherapy with autologous stem-cell support in the treatment of high-risk, primary breast cancer.
    Tecnologica MAP Suppl; 1999 Jan; ():8-10. PubMed ID: 10346740
    [No Abstract]   [Full Text] [Related]  

  • 9. "Tandem" high-dose chemoradiotherapy with autologous stem-cell support in the treatment of newly diagnosed or responsive multiple myeloma.
    Tecnologica MAP Suppl; 1998 Feb; ():32-4. PubMed ID: 10183358
    [No Abstract]   [Full Text] [Related]  

  • 10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous chondrocyte transplantation.
    Tecnologica MAP Suppl; 2000 Sep; ():3-12. PubMed ID: 11503677
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreas retransplantation.
    Tecnologica MAP Suppl; 2001 Dec; ():33-7. PubMed ID: 11933940
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy sensitivity and resistance assays.
    Tecnologica MAP Suppl; 2000 Jun; ():3-6. PubMed ID: 11067680
    [No Abstract]   [Full Text] [Related]  

  • 14. Transplanting adult patients with hematopoietic stem cells from placental and umbilical cord blood.
    Tecnologica MAP Suppl; 2001 Dec; ():38-41. PubMed ID: 11933941
    [No Abstract]   [Full Text] [Related]  

  • 15. Off-label uses of trastuzumab.
    Tecnologica MAP Suppl; 1999 Apr; ():22-3. PubMed ID: 10848167
    [No Abstract]   [Full Text] [Related]  

  • 16. Endovascular repair of abdominal aortic aneurysm.
    Tecnologica MAP Suppl; 2001 Apr; ():3-6. PubMed ID: 11718145
    [No Abstract]   [Full Text] [Related]  

  • 17. Placental and umbilical cord blood as a source of stem cells for hematopoietic support (Executive summary file).
    Tecnologica; 1996 Oct; ():7-10. PubMed ID: 10179815
    [No Abstract]   [Full Text] [Related]  

  • 18. Colony-stimulating factor priming for collection of peripheral blood stem cells.
    Tecnologica; 1995 May; ():7-8. PubMed ID: 10168290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.
    Dey BR; McAfee S; Sackstein R; Colby C; Saidman S; Weymouth D; Poliquin C; Vanderklish J; Sachs DH; Sykes M; Spitzer TR
    Biol Blood Marrow Transplant; 2001; 7(11):604-12. PubMed ID: 11760148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.
    Resnick IB; Shapira MY; Slavin S
    Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.